April 21, 2018 4:56 PM ET

Pharmaceuticals

Company Overview of JDS Therapeutics, LLC

Key Executives for JDS Therapeutics, LLC

NameBoard RelationshipsTitleAge
Michael S. Satow 21 RelationshipsChief Executive Officer, President and Director--
Gregg A. Bresner CFANo RelationshipsChief Financial Officer--
Jed Rosenbaum No RelationshipsVice President of Strategy and Business Development--
James R. Komorowski MS,CNSNo RelationshipsVice President of Scientific and Regulatory Affairs--
Michael V. Quinn No RelationshipsExecutive Director of Sales--

JDS Therapeutics, LLC Board Members*

NameBoard RelationshipsPrimary CompanyAge
Phillip M. Satow 42 RelationshipsNutrition 21, Inc.75
Michael S. Satow 21 RelationshipsJDS Therapeutics, LLC--
Martin G. Friedman 13 RelationshipsBioPharma Credit PLC52
Joseph R. Gregory 23 RelationshipsBeliefnet, Inc.62
Robert F. Johnston 13 RelationshipsExSAR Corporation81
View All Board Members

JDS Therapeutics, LLC Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
319.3K
Bonus
272.5K
Total Short Term Compensation
323.4K
Total Value of Options
10.1M
Compensation as of Fiscal Year
JDS Therapeutics, LLC CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

MedReleaf Corp. Announces Executive Changes
April 06, 2018 6:08 PM ET
Lyka Labs Limited Announces Board Changes
April 06, 2018 11:45 AM ET
True Nature Holding, Inc. Appoints Jay Morton to the Positions of President and Interim Chief Executive Officer
April 06, 2018 10:07 AM ET
Shield Therapeutics plc Appoints Rolf Hoffmann as Non-Executive Director
April 06, 2018 6:01 AM ET
Ipsen Names Ivana Magovcevic-Liebisch as New Executive Vice President and Chief Business Officer
April 05, 2018 5:31 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact JDS Therapeutics, LLC, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.